Showing results (301-310 of 408) with videos related to
Sort By:
Pageof 41
BMJ Open|February 17, 2021
Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1)Nicole Krause, Karin Riemann-Lorenz, Tanja Steffen, et al.Journal of Cardiac Failure|May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and designFarooq H Sheikh, William T Abraham, Philip B Adamson, et al.Trials|July 8, 2022
Implementation, mechanisms of change and contextual factors of a complex intervention to improve interprofessional collaboration and the quality of medical care for nursing home residents: study protocol of the process evaluation of the interprof ACT intervention packageLinda Steyer, Christian Kortkamp, Christiane Müller, et al.Circulation|January 21, 2021
Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress TrialSören J Backhaus, Torben Lange, Elisabeth F George, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 18, 2020
Impact of COVID-19 outbreak on regional STEMI care in GermanyKarl Heinrich Scholz, Björn Lengenfelder, Christian Thilo, et al.Journal of Cardiac Failure|September 30, 2025
Intravenous Ferric Carboxymaltose in Ischemic Versus Non-Ischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2Muhammad Shahzeb Khan, Javed Butler, Mahir Karakas, et al.Heart (British Cardiac Society)|September 15, 2023
QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillatorsKaterina Hnatkova, Irena Andršová, Tomáš Novotný, et al.Statistics in Biopharmaceutical Research|June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19Nigel Stallard, Lisa Hampson, Norbert Benda, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2025
Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis - Results of the randomised controlled POWER@MS1 trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.Contemporary Clinical Trials Communications|June 2, 2020
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot studyAhmed Abdelhak, Andre Huss, Alexander Stahmann, et al.Pageof 41